Office location

Urology - Third
8635 W Third St #1070W
Los Angeles


  • Urology

    Provider Info






    24 years


    • UCLA
      Residency - Completed 2003
    • University of California, Davis
      Medical School - Completed 1997
    • UCLA
      Undergraduate - Completed 1993


    Stephen Freedland, MD, is director of the Center for Integrated Research in Cancer and Lifestyle, co-director of the Cancer Genetics and Prevention Program and associate director for Faculty Development at the Samuel Oschin Comprehensive Cancer Institute. He is a faculty physician in the Division of Urology at the Cedars-Sinai Department of Surgery. Freedland's clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia and prostate cancer. His approach toward cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional Western medicine with complementary holistic interventions. His research interests include urological diseases and the role of diet, lifestyle and obesity in prostate cancer development and progression, as well as prostate cancer among racial groups and risk stratification for men with prostate cancer. Freedland has published over 400 studies, and his research has appeared in the Journal of the American Medical Association, Journal of the National Cancer Institute, Journal of Clinical Oncology, Journal of Urology, Cancer Prevention Research, Cancer and BJUI, among others. Freedland is an active reviewer for more than 50 journals. He sits on the editorial board for Cancer Prevention Research, European Urology, International Journal of Urology, Nature Reviews Urology and BJUI, and serves as editor-in-chief for Prostate Cancer and Prostatic Diseases and as a consulting editor for European Urology. Freedland earned his MD from the University of California, Davis. He completed a residency in urology at UCLA and a fellowship in urological oncology at Johns Hopkins. Before joining Cedars-Sinai, he was at Duke University, where he specialized in surgical oncology and urologic oncology, and served as an associate professor in the Division of Urology.


    • Lin PH, Aronson WJ, Freedland SJ. Nutrition, dietary interventions and prostate cancer: the latest evidence. BMC Med. 2015;13:3.
    • Freedland SJ. The effect of diet and supplements on prostate cancer. Clin Adv Hematol Oncol. 2014;12(8):538-540.
    • Lin PH, Freedland SJ. Lifestyle and lower urinary tract symptoms: what is the correlation in men? Curr Opin Uro. 2015; 25(1):1-5.
    • Freedland SJ, Choeurng V, Howard L, De Hoedt A, du Plessis M, Yousefi K, Lam LL, Buerki C, Ra S, Robbins B, et al. Utilization of a genomic classifier for prediction of metastasis following salvage radiation therapy after radical prostatectomy. Eur Urol. 2016 Jan 21. [Epub ahead of print].


    Board Certifications

    • Board Certified in Urology

    Awards & Activities

    • Who's Who in Medicine and Healthcare - 2003-present
    • Editor-in-Chief: Prostate Cancer and Prostatic Diseases - 2010-present
    • Who's Who in America - 2011-present

    Patient Ratings & Comments Learn more


    Average Rating:
    4.9 / 5
    129 Ratings

    Rating Breakdown

    five star (118):
    four star (11):
    three star (0):
    two star (0):
    one star (0):


    By Cedars-Sinai Patienton Jan 08, 2021

    Dr. Freedland is an absolutely fully informed doctor with a most calming and caring manner. I felt totally heard, cared for and competently advised. This was my initial visit and my transition was comfortable and professional.

    By Cedars-Sinai Patienton Dec 15, 2020

    Overall, an excellent experience and the misscommunication regarding the records did not seem to have a major impact on the outcome

    By Cedars-Sinai Patienton Dec 11, 2020

    Excellent knowledge